Trade name: Empliciti®
Elotuzumab is the generic name for the trade name, Empliciti In some cases, health care professionals may use the trade name, Empliciti, when referring to the generic drug name, elotuzumab.

Drug type: Elotuzumab is an anti-cancer ("antineoplastic" or "cytotoxic") chemotherapy drug. This medication is classified as a "monoclonal antibody (anti SLAMF7)". (For more detail see "How Elotuzumab Works" below.)

What Elotuzumab Is Used For :
  • Elotuzumab is used in combination with lenalidomide and dexamethasone for patients with multiple myeloma who have received 1 to 3 prior therapies.

Note: If a drug has been approved for one use, physicians may elect to use this same drug for other problems if they believe it may be helpful.

How Elotuzumab Is Given :
  • Elotuzumab is given as a slow IV infusion. You will receive multiple pre-medications prior to the start of the elotuzumab infusion Elotuzumab is usually given as 8 weekly infusions, followed by an infusion every 2 weeks. You would also be taking oral medications, lenalidomide and dexamethasone as prescribed.

The amount of elotuzuman that you will receive depends on many factors, including your height and weight, your general health or other health problems, and the type of cancer or condition you have. Your doctor will determine your exact dosage and schedule.